Description
JEMPERLI is a prescription medicine used to treat adults with:
- a kind of uterine cancer called endometrial cancer (EC)
- JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:
- when your cancer has spread outside your uterus (advanced) or,
- your cancer has returned.
- JEMPERLI may be used alone:
- when a laboratory test shows that your tumor is mismatch repair deficient (dMMR), and
- your cancer has returned, or it has spread (advanced EC), and
- you have received chemotherapy that contains platinum and it did not work or is no longer working, and
- your cancer cannot be treated by surgery or radiation.
- JEMPERLI may be used in combination with the chemotherapy medicines, carboplatin and paclitaxel, and then after that JEMPERLI may be used alone:
- a kind of cancer that is shown by laboratory test to be dMMR solid tumor. JEMPERLI may be used alone to treat:
- cancer that has returned or has spread (advanced cancer) and,
- has progressed during treatment or after treatment, and you have no satisfactory treatment options.
- This use is approved based on how many patients responded to treatment and how long they responded. Studies are ongoing to confirm the clinical benefit of JEMPERLI for this use.
It is not known if JEMPERLI is safe and effective in children.
Additional information
| Brand | JEMPERLI |
|---|---|
| Generic name | Dostarlimab-gxly injection |
| Form | Parenteral |
| Strength | 500mg/10mL |
| Manufacturer | GlaxoSmithKline |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.